EU approves AstraZeneca drug Imfinzi
Photo: Fredrik Sandberg/TT

EU approves AstraZeneca drug Imfinzi for operable, early and locally advanced stomach cancer

AstraZeneca's drug Imfinzi has been approved in the EU for the treatment of certain types of stomach cancer in combination with chemotherapy.

Advertisement

According to a press release from the pharmaceutical company, the European Commission's approval covers the treatment of adult patients with operable, early, and locally advanced gastric cancer.

The approved treatment includes two cycles of Imfinzi in combination with chemotherapy before and after surgery, followed by doses of Imfinzi alone.

Stomach cancer is the fifth most common cause of cancer death globally, with nearly one million people diagnosed each year.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All